Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INTERPARFUMS INC Regulatory Filings 2015

Apr 23, 2015

31321_rns_2015-04-23_8d249fce-d4de-4bae-8457-a9e9af24afbd.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

8-K 1 v408164_8k.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported):

April 23, 2015

Inter Parfums , Inc.

(Exact name of registrant as specified in its charter)

Delaware 0-16469 13-3275609
(State or other jurisdiction of incorporation or organization) Commission File Number (I.R.S. Employer Identification No.)

551 Fifth Avenue, New York, New York 10176

Field: Rule-Page

Field: /Rule-Page

(Address of Principal Executive Offices)

  1. 983.2640

Field: Rule-Page

Field: /Rule-Page

(Registrant's Telephone number, including area code)

Field: Rule-Page

Field: /Rule-Page

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Field: Page; Sequence: 1

Field: /Page

Item 2.02 Results of Operations and Financial Condition.

Certain portions of our press release dated April 23, 2015, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein and are filed pursuant to this Item 2.02. They are as follows:

· Portions of the 1 st paragraph relating to consolidated net sales for the first quarter ended March 31, 2015

· The 2 nd paragraph (table) relating to net sales for the first quarter ended March 31, 2015

· Portions of the 3 rd paragraph relating to net sales of European operations for the first quarter ended March 31, 2015

· The 4 th paragraph relating to net sales of United States operations for the first quarter ended March 31, 2015.

Item 7.01 Regulation FD Disclosure .

Certain portions of our press release dated April 23, 2015, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein and are filed pursuant to this Item 7.01 and Regulation FD. They are as follows:

· Portions of the 1 st paragraph relating to plans to release results

· Portions of the 3 rd paragraph relating to an anticipated product launch of European operations

· The 5 th paragraph relating to 2015 guidance

· The 7 th paragraph relating to forward looking information

· The balance of such press release not otherwise incorporated by reference in Item 2.02.

Item 9.01 Financial Statements and Exhibits.

99.1 Our press release dated April 23, 2015.

Field: Page; Sequence: 2

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated: April 23, 2015
By: /s/ Russell Greenberg
Russell Greenberg, Executive Vice President

Field: Page; Sequence: 3; Options: Last

Field: /Page